| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Inc / Ma (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.69M | - | |
| COO | 63.4K | $28.81M | - | |
| VP | 51.1K | $23.23M | - | |
| VP | 42.3K | $19.23M | - | |
| Other | 24.0K | $10.92M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | Altshuler David48 | EVP, Chief Scientific Officer | Sell | 54 | $430.93 | $23,270.22 | -0.2% | +6.9% | -0.7% | |
| May 15, 2024 | Arbuckle Stuart A | EVP, COO | Sell | 69 | $430.93 | $29,734.17 | -0.1% | +6.9% | -0.7% | |
| May 2, 2024 | Bhatia Sangeeta N.48 | Director | Sell | 467 | $402.95 | $188,177.65 | -9.5% | +23.9% | +25.2% | |
| Apr 2, 2024 | Ambrose Kristen | SVP &Chief Accounting Officer | Sell | 240 | $419.00 | $100,560.00 | -3.1% | +15.1% | +18.1% | |
| Feb 26, 2024 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 354 | $425.70 | $150,697.80 | -0.6% | +3.1% | +10.8% | |
| Feb 26, 2024 | Sachdev Amit | EVP Chief Patient &Ext Af Off | Sell | 3,004 | $425.70 | $1,278,802.80 | -5.2% | +3.1% | +10.8% | |
| Feb 26, 2024 | Ambrose Kristen | SVP &Chief Accounting Officer | Sell | 883 | $425.70 | $375,893.10 | -10.0% | +3.1% | +10.8% | |
| Feb 26, 2024 | Atkinson Edward Morrow III49 | EVP, Chief Technical Ops. Off. | Sell | 883 | $425.70 | $375,893.10 | -5.2% | +3.1% | +10.8% | |
| Feb 26, 2024 | Arbuckle Stuart A | EVP, COO | Sell | 5,034 | $425.70 | $2,142,973.80 | -9.2% | +3.1% | +10.8% | |
| Feb 26, 2024 | Altshuler David48 | EVP, Global Research And CSO | Sell | 4,239 | $425.70 | $1,804,542.30 | -14.1% | +3.1% | +10.8% |